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Abstract 
We report the usefulness of measuring functional liver volume in 2 patients undergoing 
hepatectomy. Case 1 involved a 47-year-old man with hepatitis B virus infection. Indocyanine 
green test retention rate at 15 min (ICGR15) was 14%. Liver uptake ratio (LHL15) by 
technetium-99m galactosyl human serum albumin (99mTc-GSA) liver scintigraphy was 0.91. 
The patient displayed hilar bile duct carcinoma necessitating right hepatectomy. After 
preoperative portal vein embolization (PVE), future remnant liver volume became 54% and 
functional volume by 99mTc-GSA became 79%. Although the permitted resected liver volume 
was lower than liver volume, scheduled hepatectomy was performed following the results of 
functional liver volume. Case 2 involved a 75-year-old man with diabetes. ICGR15 was 27.4% 
and LHL15 was 0.87. The patient displayed bile duct carcinoma located in the upper bile duct 
with biliary obstruction in the right lateral sector. The right hepatectomy was scheduled. After 
PVE, future remnant volume became 68% and functional volume became 88%. Although 
ICGR15 was worse as 31%, planned hepatectomy was performed due to the results of 
functional volume. In the liver with biliary obstruction or portal embolization, functional liver 
volume is decreased more than morphological volume. Measurement of functional volume 
provides useful information for deciding operative indication.  
 
Key words: Bile duct carcinoma• Technetium-99m galactosyl human serum albumin liver 
scintigraphy• Functional liver volume• Biliary obstruction• Portal vein embolization 
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Introduction 
Incidence of postoperative hepatic failure in hilar bile duct carcinoma has markedly decreased 
in recent years following the introduction of adequate preoperative evaluation of hepatic 
function and estimation of resected liver volume, induction of preoperative portal vein 
embolization (PVE) and improvements in perioperative management.1 Child-Pugh 
classification or indocyanine green (ICG) test is classically used to define the indications for 
radical operations. 2  Furthermore, Makuuchi’s criterion applying ICG retention rate at 15 min 
(ICGR15) for operative procedures has been often applied in Japan, and is suitable for 
hepatectomy in primary or metastatic liver tumors. 3  However, in cases involving hepatectomy 
for bile duct carcinomas, limitations apply to this criterion because of increased total bilirubin 
levels or poor ICG results due to biliary obstruction. Regardless of PVE and preoperative 
biliary drainage, total bilirubin level and result of ICG testing are unimproved and the operation 
must be delayed for a long time in some patients until improvement of such liver functions is 
seen. 4 Liver scintigraphy has been used to evaluate functional liver reserve and evaluation of 
the separated liver area is possible using this method. 5 Liver volume represents another piece of 
useful information to define operative indications, and is usually measured by computed 
tomography. 2-4, 6-8 In cases of PVE, both morphological liver volume and functional liver 
volume may change before and after embolization. Asialoglyco-protein receptors on 
hepatocytes reflect functional liver cells. 9, 10 Using scintigraphy, functional hepatic volume in 
the separated lobe of the liver can also be measured by applying single-photon emission 
computed tomography (SPECT). 10-16 As a result, technetium-99m galactosyl human serum 
albumin (99mTc-GSA) scintigraphy provides information about both liver function and the 
volume of active liver, and should be useful in selecting the most appropriate hepatectomy. We 
also hypothesize that functional volume shifts from the injured liver by biliary obstruction or 
PVE to counterparts much more than morphological liver volume. We reported two bile duct 
Nanashima et al., Page 4  
carcinoma patients in whom measurement of functional liver volume was considered useful in 
deciding operative indications.  
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METHODS 
Evaluation of liver functions for hepatectomy 
Child-Pugh classification is basically evaluated and only patients with Child-Pugh A are 
selected for major hepatectomy. In our hospital, the permitted volume of liver to be resected is 
determined preoperatively based on ICGR15 using Takasaki’s formula. A dose of 0.5 mg 
ICG/kg body weight was injected intravenously and ICGR15 was measured using a photopiece 
applied to the fingertip (Sumitomo Electric, Tokyo, Japan) without blood sampling. 15 
Estimated resected liver volume, excluding tumor volume, is measured by CT volumetry. 4, 8 
Essentially, the planned hepatectomy is performed where permitted resected volume of the liver 
is greater than estimated resected volume of the liver.  In cases where permitted resected 
volume is less than estimated volume, preoperative PVE is selected according to our criterion. 
16 Preoperative PVE was performed in 10 of 20 hilar bile duct carcinoma (HBDC) patients. 
Liver uptake ratio at 15 min (LHL15) by 99mTc-GSA scintigraphy and serum hyaluronic acid 
level were also examined preoperatively, along with ICGR15 and other functional liver 
parameters. 17, 19 Based on previous studies, LHL15 >0.87 was an indication for major 
hepatectomy. When dissociation between ICGR15 and LHL15 was observed, preference was 
given to the results of LHL15. 
 
Volumetric measurement by CT and 99mTc-GSA liver scintigraphy 
Morphological volume was measured using contrast CT. 2-4, 6-8 Serial transverse scans at 0.7-cm 
intervals were downloaded onto a personal computer. Using NIH Image software (Scion Co., 
Frederick, ML, USA), actual areas without tumors and large vessels in each liver slice were 
traced and measured. Hepatic volume of each hemi-liver was then measured by summation of 
areas in each slice. All patients received 3 mg (185 MBq) of 99mTc-GSA (Nihon Medi-Physics, 
Nishinomiya, Japan) as a bolus dose into the antecubital vein. Images were obtained with a 
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large field-of-view gamma camera (Picker PRISM-2000; Picker Prism International, Cleveland, 
OH) equipped with a high resolution, parallel-hole collimator centered on the liver and 
precordium. Sequential abdominal digital images (128  128 matrix) were acquired to an 
on-line nuclear data processor (Odyssey Series; Picker Prism International) at 30 s/frame for 
the first 16 min after injection. SPECT images were acquired after the dynamic study. 10, 14-16, 18, 
19 Each set of projection data was obtained in a 128  128 matrix, and 120 projections (3/step, 
15 s/projection) were acquired. A Butterworth filter was used as the pre-reconstruction filter, 
and final reconstruction was performed with a Ramp filter. Attenuation correction was 
performed using Chang’s procedure and a value of 0.09 cm-1 was used as the effective 
attenuation correction coefficient. 14, 18 Transaxial SPECT images were reconstructed using 
3.9-mm slice thickness (Fig. 1). The border between right and left hemi-livers was manually 
determined through the gallbladder bed and inferior vena cava. A cut-off level was set at 40% of 
maximum counts of the liver, as this level yielded the closest results to actual volume from a 
phantom study in the radiology department at our institute (unpublished data).  
 
Technique of portal vein embolization and evaluation 
The approach to the right portal vein was direct catheterization of percutaneous transhepatic 
puncture. 16 Substances used for embolization comprised a mixture of 0.6 g of gelatin pieces 
(Spongel; Astellas Pharma, Tokyo, Japan) and 5 ml lipiodol (Schering, Berlin, Germany) in 
Case 1 and 1 g of 5% ethanolamine oleate iopamiodole (Oldamin; Takeda Pharma, Osaka, 
Japan) in Case 2. Permanent embolization materials were not used. Embolization was 
completed when the entire right portal vein was completely occluded. At 14 days after PVE, 
hepatic volumes of the unembolized liver and embolized liver (liver to be resected) were 
reassessed by CT volumetry, and liver function was also reassessed by 99mTc-GSA scintigraphy. 
Surgical resection of the liver was performed at 21 days after PVE.  




A 47-year-old man presented with mental disorder and chronic hepatitis B virus infection. He 
reported abdominal discomfort and liver dysfunction was apparent. Intraductal papillary 
growing-type hilar bile duct carcinoma was identified spreading to the right liver (Fig. 2). 
Extended right hepatectomy with resection of the caudate lobe and extrahepatic bile duct was 
therefore planned. Hepatitis B virus antigen was positive, but hepatitis C antibody was negative. 
Total bilirubin level was slightly increased at 1.3 mg/dl, although parameters of liver function 
were almost stable. Serum hyaluronic acid level was 70 ng/ml. Liver damage was grade A and 
ICGR15 and K value were 14% and 0.124, respectively. LHL15 by 99mTc-GSA liver 
scintigraphy was 0.91. Table 1 shows liver volume and functional liver volume in the right and 
left liver, respectively. Liver volumes between CT volumetry and GSA volumetry were almost 
identical. Permitted resected liver volume by Takasaki’s formula was 54% in case of chronic 
injured liver. According to Makuuchi’s criterion, left hepatectomy was a limit of hepatic 
resection due to the results of ICGR15. Estimated resected volume was beyond the permitted 
volume and PVE in the right liver was therefore performed. After preoperative PVE, embolized 
liver volume became atrophic and functional liver volume in the embolized liver was still 
decreased in comparison with liver volume by CT volumetry (Table 2; Fig. 3A-D). Future 
remnant liver volume was increased at 54% and functional liver volume was more increased, at 
79%. While waiting for hepatectomy, obstructive jaundice progressed and total bilirubin level 
reached 11.5 mg/dl. Percutaneous transhepatic biliary drainage was performed and jaundice 
improved. However, ICGR15 worsened slightly to 18%. Permitted resected liver volume at this 
point was 46%, at the borderline on CT volumetry. However, as LHL15 improved to 0.97 and 
functional volume was still lower than permitted volume, scheduled hepatectomy was 
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performed on day 38 after PVE. Although massive ascites was observed and total bilirubin 
level had increased by day 10 to 6.5mg/dl, these values gradually improved. Pneumothorax and 
related pyothorax occurred on day 35 and second operation was performed. Remnant liver 
volume increased by 20% compared to that at day 14 after PVE and the patient was eventually 
discharged in healthy condition on day 85. 
 
Case 2 
A 75-year-old man with diabetes presented with abdominal discomfort in the upper abdomen 
and liver dysfunction was identified at the clinic. The patient displayed bile duct carcinoma 
located in the upper and middle bile duct with biliary obstruction and narrowing of the portal 
vein in the right lateral sector (Fig. 4). The right liver was markedly atrophic and right 
hepatectomy was planned. Hepatitis B virus antigen was positive. Total bilirubin level was 
increased to 1.6 mg/dl. Serum hyaluronic acid level was 96 ng/ml. Liver damage was grade A 
and ICGR15 and K value were 27% and 0.083, respectively. LHL15 by 99mTc-GSA liver 
scintigraphy was 0.87. Table 3 shows liver volume and functional liver volume in the right and 
left liver, respectively. Liver volumes by GSA volumetry (i.e., functional volume) were 
markedly lower in the right liver and higher in the left liver compared with volume by CT 
volumetry. Permitted resected liver volume by Takasaki’s formula was 49% in case of chronic 
liver injury. Based on Makuuchi’s criterion, subsegmental resection was a limit of hepatic 
resection due to the results of ICGR15. Based on CT volumetry, estimated resected volume was 
beyond the permitted volume, whereas GSA volumetry allowed right hepatectomy. PVE in the 
right liver was eventually performed to reduce operative risk as much as possible at this point. 
After PVE, functional liver volume in the embolized liver was markedly decreased compared 
with liver volume on CT volumetry (Fig. 5A-D). Future remnant liver volume reached 68% and 
functional volume became 88% (Table 4). Although ICGR15 worsened to 31.4% after 
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embolization, the planned hepatectomy was performed based on functional volume. Scheduled 
right hepatectomy with resection of extrahepatic bile duct and right caudate lobe was performed 
on day 21 after PVE. Remnant liver volume at day 24 after hepatectomy was increased by 14% 
compared to that on day 14 after PVE. Maximum total bilirubin level was 2.6 mg/dl. The 
patient did not have any complications and was discharged on day 25 after hepatectomy. 
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Discussion 
As a relatively new reliable test to assess hepatic functional reserve, 99mTc-GSA scintigraphy 
has been used in patients with liver disease. 18, 19 This test shows live hepatic cells. We have 
previously reported the clinical significance of 99mTc-GSA scintigraphy in patients with various 
hepatic backgrounds who underwent hepatic resection. 17, 20 The result of 99mTc-GSA 
scintigraphy is often dissociated from the results of ICG testing in patients with chronic 
hepatitis and vascular shunt or icteric liver. 17, 21 In such situations, 99mTc-GSA scintigraphy is 
more reliable for the evaluation of liver function than ICG testing. Functional liver volume in 
99mTc-GSA scintigraphy changes more dynamically than morphological volume after PVE. 20 
Atrophic or damaged areas of liver by biliary obstruction due to tumor invasion or PVE may 
contribute to a result of poor liver function for the whole liver. Evaluation by other useful 
functional tests or examination of separated liver functions in injured and healthy liver (i.e., 
future remnant liver) is thus necessary. ICG concentration in drained bile juice was analyzed in 
separated parts of liver by Uesaka et al. 22 and Nagino et al. 23 However, preoperative biliary 
drainage is not always possible in HBDC patients and this method thus cannot be performed 
routinely. Application of 99mTc-GSA scintigraphy seems likely to address the limitations of 
these liver function tests, as this test can evaluate separated liver functions in any situation of 
background liver function. Although the reliability of 99mTc-GSA scintigraphy compared to 
ICGR15 or other liver function has not yet been clarified, this test appears promising. 
In hepatic resection of HBDC, preoperative adequate assessment of liver functional reserve 
is quite necessary, as the risk of postoperative morbidity and mortality is still high regardless of 
improvements in perioperative management, including induction of PVE. 1 In the present cases, 
serum bilirubin levels increased with biliary tumor stenosis. In Case 1, biliary obstruction 
progressed during waiting for surgery and ICGR15 worsened after PVE. If the ICG test alone 
had been applied to decide operative indications, timing of hepatectomy would have been 
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further delayed. In Case 2, total bilirubin level was already at a mildly high level and results of 
ICGR15 were not good. Furthermore, ICGR15 worsened after PVE. This case would not 
generally have been considered a suitable candidate for hemihepatectomy based only on the 
results of the ICG test. In HBDC patients, ICG clearance test cannot be applied in cases with 
increased bilirubin levels. 4 Furthermore, intrahepatic blood flow in the embolized liver is 
decreased after PVE, so ICG clearance may be delayed in the whole liver. Nagino et al. applied 
the index of (ICG K-value (disappearance rate)  future remnant volume (%) of the liver).1 This 
index >0.05 is a criterion for major hepatectomy in the Nagoya series, which has the highest 
number of hepatectomies for HBDC in the world. By applying this criterion, the indications for 
hemi-hepatectomy were a borderline and these criteria would be more reliable than Makuuchi’s 
criterion 3 or Takasaki’s formula 14 in cases of HBDC.  
In tests of 99mTc-GSA scintigraphy, both LHL15 24, 25 and heart activity at 15 min by heart 
activity at 3 min (HH15) 25, or maximal removal rate (Rmax) 18, are reliable as non-invasive 
methods for evaluating hepatic functional reserve without blood sampling. Since 1996, our 
department has used 99mTc-GSA scintigraphy preoperatively in combination with ICGR15 and 
conventional liver function tests in patients with liver diseases including HBDC. 17. In our 
previous analysis, approximately 16 of 201 patients with liver diseases (8%) showed marked 
differences between ICGR15 and LHL15 on 99mTc-GSA scintigraphy, including 5 HBDC 
patients. 17 In the present series, LHL15 provided a much better reflection of clinical outcomes 
after hepatectomy than ICGR15. Since completing this study, we have preferred to apply 
LHL15 to decide operative indications for hepatectomy in case of discrepancies between both 
liver functions, and decisions in the present cases were performed based on this reason. 
Eventually, the present cases overcame the major hepatectomy despite the poor ICG results 
mentioned above.  
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Measurement of functional hepatic volume in separate regions of the liver by 99mTc-GSA 
scintigraphy has recently become available and we have reported preliminary comparisons with 
morphological liver volume. 9-11 Although the morphological and functional liver volumes 
were significantly correlated 20, both volumes were not identical basically. Furthermore, as 
described above, both volumes may be dissociated in the situation of injured livers such as a 
patient undergoing PVE or with biliary obstruction. To the best of our knowledge, the 
usefulness or evaluation of 99mTc-GSA scintigraphy has not been fully examined in HBDC 
patients with biliary obstruction or PVE. 26 The present report showed differences of functional 
hepatic volume in injured liver by biliary stenosis and changes in functional hepatic volume 
after PVE, which were more significant than those in morphological liver volume on CT. We 
believe that functional shift may occur from the injured liver to the healthy liver following 
biliary tumor occlusion or PVE. In such cases, the indications for major hepatectomy might be 
suitable to decide markedly reduced functional volume. The functional mass detected by 
asialoglycoprotein receptor might be decreased by hepatic injury, which cannot be detected by 
enhanced CT. Measuring functional liver volume by 99mTc-GSA scintigraphy is useful to 
accurately evaluate the future remnant liver in comparison with evaluation by CT. 
In the present cases, we hypothesized that changes in embolized lobe after PVE would be 
dramatic due to cell damage secondary to reduction of blood supply. Hypertrophy of the 
unembolized left liver as assessed by 99mTc-GSA scintigraphy did not differ substantially from 
that as assessed by CT volumetry, contrary to results in the embolized liver. Sugai et al. 12 also 
reported that functional volume in the unembolized liver did not significantly increase, but that 
the increase in liver uptake density was marked. Although functional shift in the unembolized 
liver could not have been prominently visible even by 99mTc-GSA scintigraphy, we speculate 
that the potential for regeneration in the remnant liver after hepatectomy might be accumulated. 
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Furthermore, the safety of major hepatectomy following PVE [27, 28] might be confirmed, since 
the embolized right liver lost much more hepatic function after PVE. 
Several reports have shown that a lower level of 99mTc-GSA clearance is associated with 
post-hepatectomy complications. 10, 22, 25, 29, 30 Functional hepatic volume would be useful for 
predicting post-hepatectomy complications. In the present study, Case 1 required long-term 
hospitalization due to complications, but jaundice recovered after 1 week. Case 2 showed no 
complications of note. A good result on 99mTc-GSA scintigraphy thus seems to indicate the 
safety of major hepatectomy. 
In conclusion, we have demonstrated the usefulness of LHL15 by 99mTc-GSA scintigraphy 
as a preoperative functional liver reserve in 2 cases of HBDC. Furthermore, functional volume 
as estimated by 99mTc-GSA is apparently decreased in the liver with biliary stenosis or 
embolization following PVE compared with that estimated by CT volumetry.  
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FIGURE LEGENDS 
Fig. 1  Transaxial SPECT images for calculating functional volume in the right and left liver. A 
line indicates a border between right and left liver. 
 
Fig. 2.  Enhanced CT for Case 1. Arrow shows intraductal tumor in the hilar bile duct. 
 
Fig. 3.  Measurement of hepatic volume in each lobe of the liver in Case 1 by A) CT and B) 
99mTc-GSA scintigraphy. C) CT finding on day 14 after PVE. D) Results of 99mTc-GSA 
scintigraphy on day 14 after PVE. An encircled area and arrows indicate an embolized right 
liver. A line indicates a border between right and left liver. 
 
Fig. 4.  Enhanced CT for Case 2. A) Coronary view. Thin arrow, bile duct tumor; dotted arrow, 
left hepatic duct; black arrowhead, right anterior hepatic duct; and white arrowhead, right 
posterior hepatic duct. B) CT angiography. Arrow shows portal vein in the right posterior 
sector. 
 
Fig. 5.  Measurement of hepatic volume in each lobe of the liver in Case 2 by A) CT and B) 
99mTc-GSA scintigraphy. C) CT findings on day 14 after PVE. D) Results of 99mTc-GSA 
scintigraphy on day 14 after PVE. An encircled area and arrows indicate an embolized right 
liver. A line indicates a border between right and left liver. 
 
Table 1  Morphological and functional liver volume in each hemi-liver
Right liver volume Left liver volume




99mTc-GSA 517 cm3 325 cm3
liver scintigraphy (60%) (40%)
Parenthesis is a rate of the whole liver volume.
Table 2  Changes of morphological and functional liver volume before and after the right 
portal vein embolization in each hemi-liver
Right liver Changes of 
volume












99mTc-GSA 517 → 137 cm3 -380cm3 325 → 515 cm3 +190cm3
volumetry (58 → 21%) (-27%) (42 → 79%) (+27%)
Parenthesis is a rate of the whole liver volume.
Table 3  Morphological and functional liver volume in each hemi-liver
Right liver Left liver
CT volumetry 400 cm3 394 cm3
(50%) (50%)
99mTc-GSA 131 cm3 596 cm3
volumetry (18%) (82%)
P th i  i   t  f th  h l  li  laren es s s a ra e o e w o e ver vo ume.
Table 4  Changes of morphological and functional liver volume before and after the right portal 
vein embolization in each hemi-liver
Right liver Changes of 
volume
Left liver Changes of 
volume







(50 → 68%) (+18%)
99mT GSA 131  62 3 69 3 596  663 3 +67 3c-
volumetry
→ cm







Parenthesis is a rate of the whole liver volume.
Figure1
Figure 2
Figure 3
A C
B D
Figure 4 A
B
Figure 5
A C
B D
